Cover Image
市場調查報告書

美國的心臟用醫療設備市場:2016∼2020年

Cardiac Medical Devices Market in the US 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 353184
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
美國的心臟用醫療設備市場:2016∼2020年 Cardiac Medical Devices Market in the US 2016-2020
出版日期: 2016年02月24日 內容資訊: 英文 71 Pages
簡介

心房纖維顫動(AF)以心律不整的一般的類型,疾病對策中心(CDC)的2015年根據的預測,美國的270萬∼610萬人被診斷心房纖維顫動,心律調節器和置入式除顫器等的心臟用醫療設備被採用。被預測美國的心臟用醫療設備市場,以2016∼2020一年更新架CAG1.82%擴大。

本報告提供美國的心臟用醫療設備市場現狀與今後的成長預測,市場趨勢,市場成長的課題,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

  • 市場焦點

第5章 美國的法律規章與償付方案

  • 心臟用醫療設備埋入相關Medicare的平均價格

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

  • CRM設備
  • 美國的CRM設備市場
  • 心臟輔助裝置
  • 美國的心臟輔助裝置市場
  • 心臟瓣膜
  • 美國的心臟瓣膜市場

第8章 推動市場的要素

  • 心臟疾病的罹患率
  • 心臟提供者的不足
  • 民眾的認識增加

第9章 促進要素的影響

第10章 市場課題

  • 產品回收
  • 心臟醫療設備的成本的高度
  • 法律規章的複雜
  • 激烈競爭
  • CRM設備的併發症

第11章 促進要素及課題的影響

第12章 市場趨勢

第13章 供應商環境

  • 競爭模式
  • 市場佔有率分析
  • Boston Scientific
  • Medtronic
  • LivaNova
  • St. Jude Medical
  • 其他值得注意的供應商

第14章 附錄

第15章 關於Technavio

圖表

目錄
Product Code: IRTNTR8830

About Cardiac Medical Devices Market in the US

Atrial fibrillation (AF), a common type of heart arrhythmia, is a heart condition when the heart beats too fast or too slow or in an irregular way. An estimation done by the Centers for Disease Control and Prevention (CDC) in 2015 shows that in the US 2.7-6.1 million people were diagnosed with AF. It is most common in the older population, among people aged 60 years or above. This condition occurs when the heart's ability to function reduces and there is a malfunction in the electrical impulses in the heart, which leads to sudden cardiac arrest or heart failure.

Cardiac output such as an irregularity in the ventricular rate can lead to diastolic dysfunction. Hence, to reduce the risk of irregular heartbeat, especially for people that are at a higher risk of arrhythmia or have recurrent arrhythmia, cardiac medical devices such as pacemaker or implantable cardioverter defibrillators (ICD) are used to help the heart's electrical activity and heart rhythm function. These devices are small and are placed below the collar bone. Heart attacks can also cause defects in the heart valves, which can be replaced by mechanical or tissue heart valves.

Technavio's analysts forecast the cardiac medical devices market in the US to grow at a CAGR of 1.82% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the cardiac medical devices market in the US for 2016-2020. Cardiac medical devices that are included in this report are implanted in the heart through minimally invasive surgeries. To calculate the market size, the report considers the revenue generated from the sales of the products.

The market is divided into the following segments based on product type:

  • Cardiac rhythm management (CRM) devices
  • Cardiac assist devices
  • Heart valve

Technavio's report, Cardiac Medical Devices Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Abiomed
  • Adam, Rouilly
  • Advanced Instrumentations
  • A.M.I. ITALIA
  • Biotronik
  • Cardioline
  • Cardia International
  • Cardiac Science (subsidiary of Opto Circuits)
  • Colibri Heart Valve
  • Corpuls
  • Edwards Lifesciences
  • EMTEL
  • Fukuda Denshi
  • HeartWare
  • Innomed
  • INSTRAMED
  • MEDIANA
  • M&B Electronic Instruments
  • Medical ECONET
  • Mindray Medical
  • Physio Control
  • PRIMEDIC
  • Prestan
  • Schiller
  • Spectranetics
  • SynCardia
  • Symetis
  • TTK Healthcare
  • WNL Products

Market driver

  • Prevalence of cardiac disorders
  • For a full, detailed list, view our report

Market challenge

  • High cost of cardiac devices
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Product offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Regulation and reimbursement scenario in US

  • Average price provided by Medicare for cardiac medical device implantation

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by product type

  • CRM devices
  • CRM devices market in US
  • Cardiac assist devices
  • Cardiac assist devices market in US
  • Heart valves
  • Heart valves market in US

PART 08: Market drivers

  • Prevalence of cardiac disorders
  • Shortage of heart donors
  • Increase in public awareness

PART 09: Impact of drivers

PART 10: Market challenges

  • Product recalls
  • High cost of cardiac devices
  • Regulatory complications
  • Intense competition
  • Complications of CRM devices

PART 11: Impact of drivers and challenges

PART 12: Market trends

  • Use of MRI in clinical applications
  • Popularity of robot-assisted surgery
  • Increase in M&A

PART 13: Vendor landscape

  • Competitive scenario
  • Market share analysis
  • Boston Scientific
  • Medtronic
  • LivaNova
  • St. Jude Medical
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

PART 15: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Progression of heart failure due to AF
  • Exhibit 03: Types of cardiac medical devices
  • Exhibit 04: Snapshot of regulatory pathway for medical devices in US
  • Exhibit 05: Reimbursement scenario of cardiac medical devices in US
  • Exhibit 06: Cardiac medical devices market in US
  • Exhibit 07: Cardiac medical devices market in US 2015-2020 ($ billions)
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Segmentation of cardiac medical devices based on products
  • Exhibit 10: Cardiac medical devices market segmentation by product type 2015
  • Exhibit 11: Segmentation of CRM devices market by product type 2015
  • Exhibit 12: Segmentation of cardiac assist devices market by product type 2015
  • Exhibit 13: Segmentation of heart valves market by product type 2015
  • Exhibit 14: CRM devices market in US 2015-2020 ($ billions)
  • Exhibit 15: Cardiac assist devices market in US 2015-2020 ($ millions)
  • Exhibit 16: Heart valves market in US 2015-2020 ($ billions)
  • Exhibit 17: Impact of drivers
  • Exhibit 18: US FDA-initiated product recalls in 2013 and 2014
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Ranking of CRM vendors 2015
  • Exhibit 21: Ranking of cardiac assist devices vendors 2015
  • Exhibit 22: Ranking of heart valves vendors 2015
  • Exhibit 23: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 24: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
  • Exhibit 26: Boston Scientific: Key takeaways
  • Exhibit 27: Medtronic: Business segmentation by revenue 2015
  • Exhibit 28: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)
  • Exhibit 29: Medtronic: Geographical segmentation by revenue 2015
  • Exhibit 30: Medtronic: Key takeaways
  • Exhibit 31: LivaNova: Business segmentation by revenue 2014
  • Exhibit 32: LivaNova: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 33: LivaNova: Key takeaways
  • Exhibit 34: St. Jude Medical: Business segmentation by revenue 2014
  • Exhibit 35: St. Jude Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 36: St. Jude Medical: Key takeaways
Back to Top